Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma

Cisplatin is one of the most effective chemotherapeutic agents commonly used for several malignancies including oral squamous cell carcinoma (OSCC). Although cisplatin resistance is a major obstacle to effective treatment and is associated with poor prognosis of OSCC patients, the molecular mechanis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Suenaga, Naoki, Kuramitsu, Mimi, Komure, Kanae, Kanemaru, Ayumi, Takano, Kanako, Ozeki, Kazuya, Nishimura, Yuka, Yoshida, Ryoji, Nakayama, Hideki, Shinriki, Satoru, Saito, Hideyuki, Jono, Hirofumi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829433/
https://ncbi.nlm.nih.gov/pubmed/31635163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados